Fundz

Concure Oncology, Inc. reported raising $7.11 Million in an initial SEC Form D filing, from an offering of $9.06 Million

PRIVATEMar 20, 2020$7.1M of $9.1M raised

Amount Raised

$7.11 Million

$7.11 Million sold, per SEC Form D (first sale Mar 20, 2020)

Round Type

Venture

Mercer IslandHealthcare

Quick answer

Concure Oncology, Inc. raised $7.11 Million in a funding round, dated March 20, 2020. Concure Oncology, Inc. is based in Mercer Island, Washington, United States.

How much did Concure Oncology, Inc. raise?
Concure Oncology, Inc. raised $7.11 Million in a funding round on March 20, 2020.
What does Concure Oncology, Inc. do?
Breast Microseed, owned by Concure Oncology, specializes in early-stage breast cancer treatment and related services.
Where is Concure Oncology, Inc. based and how big is it?
Concure Oncology, Inc. is based in Mercer Island, Washington, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Concure Oncology, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CMTx Biotech, Inc. raised an undisclosed amount on May 4, 2020.
  • CAMBRIDGE SCIENCE Corp raised $250K (Seed) on May 4, 2020.
  • Medable Inc. raised $25M (Funding Round) on May 4, 2020.
  • MedsByMe, Inc. raised $445K (Seed) on May 4, 2020.
  • Ceptur Therapeutics, Inc. raised $75K (Pre-Seed) on May 4, 2020.
  • ROM Technologies raised $448M on May 4, 2020.

Who to call at Concure Oncology, Inc., and when

A new round usually means Concure Oncology, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Concure Oncology, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Concure Oncology, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Concure Oncology, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Concure Oncology, Inc.

Location

3010 77TH AVENUE SE

Mercer Island, Washington, United States

About

Breast Microseed, owned by Concure Oncology, specializes in early-stage breast cancer treatment and related services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Concure Oncology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Concure Oncology, Inc.'s next move

See what Strategic adds

Concure Oncology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.